BeiGene, Ltd. Peer Comparison

Metric Value Ranking
Market Cap $20.2 Billion 1/17 BGNE
$20.2B		 INCY
$13.3B		 BMRN
$12.6B		 PCVX
$10.6B		 RXDX
$9.6B		 IMGN
$8.7B		 ASND
$7.5B		 LEGN
$6.6B		 BPMC
$6.6B		 IONS
$4.9B		 KRYS
$4.4B		 MRTX
$4.1B		 APLS
$3.5B		 IMVT
$3.3B		 ARWR
$2.3B		 TVTX
$2.1B		 IMAB
$73.9M
Gross Margin 83% 7/17 RXDX
100%		 IMGN
98%		 BPMC
98%		 INCY
92%		 MRTX
91%		 KRYS
90%		 BGNE
83%		 APLS
81%		 ASND
81%		 TVTX
80%		 BMRN
74%		 LEGN
65%		 IONS
39%		 ARWR
0%		 IMAB
0%		 IMVT
0%		 PCVX
0%
Profit Margin -12% 9/17 KRYS
32%		 IMGN
27%		 BMRN
14%		 INCY
9%		 ARWR
0%		 IMAB
0%		 IMVT
0%		 PCVX
0%		 BGNE
-12%		 APLS
-33%		 BPMC
-44%		 LEGN
-78%		 TVTX
-87%		 IONS
-100%		 MRTX
-100%		 ASND
-100%		 RXDX
-100%
EBITDA margin -5% 5/17 IMGN
27%		 KRYS
27%		 BMRN
16%		 INCY
16%		 BGNE
-5%		 BPMC
-26%		 APLS
-38%		 LEGN
-69%		 TVTX
-87%		 ARWR
-100%		 IMAB
-100%		 IMVT
-100%		 PCVX
-100%		 ASND
-123%		 IONS
-196%		 MRTX
-1049%		 RXDX
-4408%
Quarterly Revenue $1.0 Billion 3/17 BMRN
$733.9B		 INCY
$1.1B		 BGNE
$1.0B		 APLS
$176.6M		 LEGN
$160.2M		 BPMC
$128.2M		 IMGN
$113.4M		 KRYS
$83.8M		 IONS
$75.7M		 ASND
$63.6M		 TVTX
$62.9M		 MRTX
$16.4M		 RXDX
$1.1M		 ARWR
$0		 IMAB
$0		 IMVT
$0		 PCVX
$0
Quarterly Earnings -$121.4 Million 13/17 BMRN
$106.1B 		INCY
$106.5M 		IMGN
$30.7M 		KRYS
$27.2M 		IMAB
-$20.5M 		RXDX
-$33.0M 		TVTX
-$54.8M 		BPMC
-$56.3M 		APLS
-$57.4M 		PCVX
-$103.1M 		ASND
-$109.0M 		IMVT
-$111.1M 		BGNE
-$121.4M 		LEGN
-$125.3M 		IONS
-$140.5M 		MRTX
-$161.9M 		ARWR
-$170.5M
Quarterly Free Cash Flow $54.7 Million 4/17 BMRN
$321.2B 		INCY
$293.2M 		KRYS
$57.8M 		BGNE
$54.7M 		APLS
$34.1M 		IMGN
$1.4M 		BPMC
-$13.7M 		PCVX
-$21.7M 		TVTX
-$23.8M 		RXDX
-$40.1M 		LEGN
-$77.9M 		IMVT
-$100.6M 		IONS
-$108.8M 		MRTX
-$143.7M 		ARWR
-$161.5M 		ASND
-$0 		IMAB
-$0
Trailing 4 Quarters Revenue $3.3 Billion 3/17 BMRN
$1.4T		 INCY
$4.1B		 BGNE
$3.3B		 IONS
$744.7M		 APLS
$675.9M		 LEGN
$520.2M		 BPMC
$434.4M		 ASND
$360.0M		 IMGN
$329.6M		 KRYS
$241.5M		 TVTX
$203.4M		 MRTX
$38.2M		 RXDX
$4.0M		 ARWR
$3.6M		 IMAB
$1.1M		 IMVT
$0		 PCVX
$0
Trailing 4 Quarters Earnings -$860.5 Million 17/17 BMRN
$733.9B 		INCY
$1.1B 		BGNE
$1.0B 		APLS
$176.6M 		LEGN
$160.2M 		BPMC
$128.2M 		IMGN
$113.4M 		KRYS
$83.8M 		IONS
$75.7M 		ASND
$63.6M 		TVTX
$62.9M 		MRTX
$16.4M 		RXDX
$1.1M 		ARWR
-$0 		IMAB
-$0 		IMVT
-$0 		PCVX
-$0
Quarterly Earnings Growth -156% 17/17 BMRN
262617% 		KRYS
182% 		IMGN
175% 		IMAB
94% 		APLS
59% 		BPMC
58% 		ASND
39% 		MRTX
7% 		IONS
4% 		RXDX
-3% 		PCVX
-11% 		INCY
-38% 		ARWR
-55% 		LEGN
-101% 		IMVT
-116% 		TVTX
-136% 		BGNE
-156%
Annual Earnings Growth 7% 9/17 KRYS
133% 		IMGN
92% 		IMAB
90% 		BPMC
76% 		APLS
51% 		LEGN
47% 		ASND
19% 		IONS
11% 		BGNE
7% 		MRTX
-2% 		RXDX
-15% 		BMRN
-25% 		ARWR
-43% 		IMVT
-68% 		PCVX
-71% 		INCY
-96% 		TVTX
-231%
Quarterly Revenue Growth 28% 8/17 BMRN
126140% 		MRTX
202% 		IMGN
127% 		BPMC
127% 		APLS
78% 		TVTX
70% 		LEGN
67% 		BGNE
28% 		INCY
24% 		ASND
20% 		KRYS
0% 		IMVT
0% 		PCVX
0% 		IONS
-47% 		RXDX
-72% 		ARWR
-100% 		IMAB
-100%
Annual Revenue Growth 29% 8/17 IMGN
90% 		BPMC
89% 		MRTX
77% 		APLS
76% 		ASND
72% 		LEGN
65% 		RXDX
32% 		BGNE
29% 		INCY
8% 		IONS
5% 		KRYS
0% 		IMVT
0% 		PCVX
0% 		TVTX
-6% 		BMRN
-23% 		IMAB
-91% 		ARWR
-94%
Cash On Hand $2.7 Billion 2/17 BMRN
$675.4B 		BGNE
$2.7B 		INCY
$1.3B 		PCVX
$1.1B 		ASND
$687.4M 		IMGN
$605.5M 		LEGN
$459.3M 		APLS
$396.9M 		IMVT
$374.7M 		KRYS
$374.0M 		IONS
$334.6M 		MRTX
$258.7M 		RXDX
$113.3M 		ARWR
$102.7M 		BPMC
$89.4M 		IMAB
$79.3M 		TVTX
$36.4M
Short Term Debt $881.5 Million 1/17 BGNE
$881.5M 		ASND
$494.2M 		TVTX
$73.9M 		BPMC
$45.0M 		IONS
$44.0M 		BMRN
$15.6M 		PCVX
$9.6M 		MRTX
$8.0M 		APLS
$6.8M 		ARWR
$6.3M 		LEGN
$4.3M 		INCY
$3.9M 		RXDX
$3.5M 		KRYS
$1.3M 		IMAB
$753,000 		IMVT
$23,000 		IMGN
-$24.9M
Long Term Debt $220.0 Million 8/17 BMRN
$594.6B		 IONS
$1.4B		 ARWR
$504.2M		 ASND
$372.5M		 LEGN
$342.2M		 BPMC
$341.5M		 TVTX
$328.5M		 BGNE
$220.0M		 APLS
$104.7M		 IMGN
$72.1M		 MRTX
$42.2M		 INCY
$28.2M		 RXDX
$26.0M		 PCVX
$18.3M		 IMAB
$3.0M		 KRYS
$0		 IMVT
$0
PE -1.00 4/17 INCY
409.53		 KRYS
83.10		 BMRN
0.10		 BGNE
-1.00		 IMGN
-1.00		 IONS
-1.00		 ARWR
-1.00		 MRTX
-1.00		 BPMC
-1.00		 APLS
-1.00		 ASND
-1.00		 IMAB
-1.00		 IMVT
-1.00		 LEGN
-1.00		 PCVX
-1.00		 RXDX
-1.00		 TVTX
-1.00
PS 6.09 12/17 RXDX
2392.62		 ARWR
654.07		 MRTX
107.82		 IMAB
66.99		 IMGN
26.48		 ASND
19.05		 KRYS
18.02		 BPMC
15.14		 LEGN
12.65		 TVTX
10.16		 IONS
6.54		 BGNE
6.09		 APLS
5.25		 INCY
3.26		 BMRN
0.01		 IMVT
-1.00		 PCVX
-1.00
PB 5.88 9/17 BPMC
21.01		 IMGN
15.54		 APLS
14.96		 RXDX
13.70		 ARWR
12.16		 IMVT
9.26		 IONS
7.35		 LEGN
5.90		 BGNE
5.88		 KRYS
4.91		 MRTX
4.35		 INCY
4.19		 PCVX
3.12		 IMAB
0.34		 BMRN
0.00		 ASND
0.00		 TVTX
0.00
PC 7.48 15/17 RXDX
84.33		 BPMC
73.62		 TVTX
56.77		 ARWR
22.62		 MRTX
15.92		 IONS
14.55		 IMGN
14.41		 LEGN
14.33		 KRYS
11.64		 ASND
10.97		 INCY
10.20		 PCVX
10.14		 APLS
8.94		 IMVT
8.71		 BGNE
7.48		 IMAB
0.93		 BMRN
0.02
Liabilities to Equity 0.70 5/17 ARWR
5.12		 IONS
3.65		 BPMC
2.83		 APLS
2.80		 BGNE
0.70		 INCY
0.58		 LEGN
0.56		 IMGN
0.46		 BMRN
0.27		 MRTX
0.19		 IMVT
0.19		 KRYS
0.11		 RXDX
0.09		 IMAB
0.07		 PCVX
0.04		 ASND
0.00		 TVTX
0.00
ROA -0.15 8/17 KRYS
5% 		BMRN
2% 		INCY
1% 		IMGN
-2% 		BPMC
-11% 		IONS
-12% 		PCVX
-14% 		BGNE
-15% 		RXDX
-19% 		LEGN
-20% 		APLS
-28% 		IMAB
-30% 		ASND
-43% 		ARWR
-53% 		MRTX
-63% 		TVTX
-70% 		IMVT
-91%
ROE -0.25 9/17 TVTX
1154% 		ASND
482% 		KRYS
6% 		BMRN
2% 		INCY
1% 		IMGN
-3% 		PCVX
-15% 		RXDX
-20% 		BGNE
-25% 		LEGN
-31% 		IMAB
-32% 		BPMC
-41% 		IONS
-54% 		MRTX
-76% 		APLS
-105% 		IMVT
-109% 		ARWR
-323%
Current Ratio 2.43 11/17 PCVX
25.05		 IMAB
15.72		 RXDX
12.47		 KRYS
10.18		 MRTX
6.17		 IMVT
6.16		 BMRN
4.77		 IMGN
3.16		 LEGN
2.80		 INCY
2.72		 BGNE
2.43		 APLS
1.36		 BPMC
1.35		 IONS
1.27		 ARWR
1.20		 TVTX
0.94		 ASND
0.92
Quick Ratio 1.13 9/17 INCY
409.53		 KRYS
83.10		 BMRN
0.10		 BGNE
-1.00		 IMGN
-1.00		 IONS
-1.00		 ARWR
-1.00		 MRTX
-1.00		 BPMC
-1.00		 APLS
-1.00		 ASND
-1.00		 IMAB
-1.00		 IMVT
-1.00		 LEGN
-1.00		 PCVX
-1.00		 RXDX
-1.00		 TVTX
-1.00
Long Term Debt to Equity 0.06 8/17 ARWR}
2.72		 IONS}
2.18		 BPMC}
1.09		 APLS}
0.44		 LEGN}
0.31		 IMGN}
0.13		 BMRN}
0.11		 BGNE}
0.06		 MRTX}
0.04		 RXDX}
0.04		 INCY}
0.01		 IMAB}
0.01		 PCVX}
0.01		 KRYS}
0.00		 IMVT}
0.00		 ASND}
-3.48		 TVTX}
-10.79
Debt to Equity 0.32 5/17 ARWR
2.75		 IONS
2.18		 BPMC
1.23		 APLS
0.47		 BGNE
0.32		 LEGN
0.31		 IMGN
0.13		 BMRN
0.11		 MRTX
0.05		 RXDX
0.04		 IMAB
0.02		 INCY
0.01		 PCVX
0.01		 KRYS
0.00		 IMVT
0.00		 ASND
-8.10		 TVTX
-13.21
Burn Rate 7.71 2/17 PCVX
9.88		 BGNE
7.71		 APLS
6.27		 IMAB
3.81		 IMVT
3.37		 LEGN
3.28		 RXDX
3.24		 ASND
2.66		 IONS
1.60		 MRTX
1.56		 BPMC
1.10		 ARWR
0.53		 TVTX
0.42		 BMRN
-8.21		 INCY
-12.50		 KRYS
-13.92		 IMGN
-17.77
Cash to Cap 0.13 3/17 BMRN
53.81		 IMAB
1.07		 BGNE
0.13		 APLS
0.11		 IMVT
0.11		 INCY
0.10		 PCVX
0.10		 KRYS
0.09		 ASND
0.09		 IMGN
0.07		 IONS
0.07		 LEGN
0.07		 MRTX
0.06		 ARWR
0.04		 TVTX
0.02		 BPMC
0.01		 RXDX
0.01
CCR -0.45 14/17 BMRN
3.03		 INCY
2.75		 KRYS
2.13		 RXDX
1.21		 ARWR
0.95		 IMVT
0.91		 MRTX
0.89		 IONS
0.77		 LEGN
0.62		 TVTX
0.43		 BPMC
0.24		 PCVX
0.21		 IMGN
0.05		 BGNE
-0.45		 APLS
-0.59		 ASND
 IMAB
EV to EBITDA -379.98 17/17 IMGN}
267.45		 KRYS}
177.39		 INCY}
66.90		 IMAB}
0.13		 BMRN}
-0.60		 IMVT}
-1.00		 PCVX}
-1.00		 ARWR}
-17.83		 MRTX}
-22.72		 IONS}
-40.24		 TVTX}
-44.44		 APLS}
-48.28		 LEGN}
-58.85		 ASND}
-118.75		 RXDX}
-194.54		 BPMC}
-206.03		 BGNE}
-379.98
EV to Revenue 5.61 11/17 RXDX
2371.62		 ARWR
768.93		 MRTX
102.36		 IMGN
24.86		 ASND
23.46		 KRYS
16.48		 BPMC
15.83		 LEGN
12.43		 TVTX
11.96		 IONS
8.03		 BGNE
5.61		 APLS
4.82		 INCY
2.95		 BMRN
-0.05		 IMVT
-1.00		 PCVX
-1.00		 IMAB
-1.45

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions